Effectiveness of a trivalent serogroup A/C/W135 meningococcal polysaccharide vaccine in Burkina Faso, 2003

Vaccine

Volumn 25, Issue SUPPL. 1, 2007, Pages

  Soriano Gabarró, Montse ^e   Toé, Laurent ^b   Tiendrebeogo, Sylvestre R M ^c   Nelson, Christopher B ^d   Dabal, Moumouni ^c   Djingarey, Mamoudou H ^b   Plikaytis, Brian ^a   Rosenstein, Nancy ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b World Health Organization Ouagadougou   (Burkina Faso)

^c MINISTÈRE DE LA SANTÉ   (Burkina Faso)

^d MERCK RESEARCH LABORATORIES   (United States)

^e GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

Effectiveness; N. meningitidis; Vaccine

Indexed keywords

MENINGOCOCCUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; EPIDEMIC; FEMALE; HUMAN; INFECTION RISK; MALE; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL; VACCINATION;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; BURKINA FASO; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; HUMANS; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS, SEROGROUP W-135; POLYSACCHARIDES, BACTERIAL; POPULATION SURVEILLANCE; SERUM BACTERICIDAL TEST; TREATMENT OUTCOME;

EID: 34547612629     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.04.048     Document Type: Article

References (16)

1. Greenwood B.M., Bradley A.K., and Wall R.A. Meningococcal disease and season in sub-Saharan Africa. Lancet 123 (1985) 67-73
2. Greenwood B. Meningococcal meningitis in Africa. Trans R Soc Trop Med Hyg 93 (1999) 341-353
3. World Health Organization. Enhanced surveillance of epidemic meningococcal meningitis in Africa: a 3-year experience. Wkly Epidemiol Rec 80 37 (2005) 313-320
4. World Health Organization. Detecting meningococcal meningitis epidemics in highly endemic African countries. WHO recommendation. Wkly Epidemiol Rec 75 38 (2000) 306-309
5. Rosenstein N.R., Perkins B.A., Stephens D.S., and Hughes J.M. Meningococcal disease. N Engl J Med 344 18 (2001) 1378-1388
6. Lingappa J.R., Al-Rabeah A.M., Hajjeh R., Mustafa T., Fatani A., Al-Bassam T., et al. Serogroup W-135 meningococcal disease during the Hajj, 2000. Emerg Infect Dis 9 6 (2003) 665-671
7. Mayer L.W., Reeves M.W., Al-Hamdan N., Sacchi C.T., Taha M.K., Ajello G.W., et al. Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electrophoretic type-37 complex. J Infect Dis 185 (2002) 1596-1605
8. World Health Organization. Meningococcal disease, serogroup W-135, Burkina Faso. Preliminary Report, 2002. Wkly Epidemiol Rec 2002; 18:152-5.
9. World Health Organization. The use of polysaccharide trivalent ACW vaccine for the control of epidemic meningococcal disease outbreaks in countries of the African meningitis belt. Recommendations from an international informal consultation. World Health Organization, Geneva 2003, WHO/CDS/CSR/GAR/2003.14.
10. Tiendrebeogo SR, Soriano-Gabarro M, Djingarey MH, Traore E, Jones J, Croisier A, et al. In: Abstracts of the 14th international pathogenic Neisseria conference, 2004. Milwaukee, WI, Milwaukee. Organizing committee of the 14th international pathogenic Neisseria conference, 2004: 41.
11. World Health Organization. Laboratory methods for the diagnosis of meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae. WHO/CDS/CSR/EDC/99/7/EN 1999.
12. Breslow NE, Day NE. Statistical methods in cancer research. The analysis of case-control studies, vol. 1. Classical methods of analysis of matched data (IARC Scientific Publication no. 32). Lyon, France: International Agency for Research on Cancer; 1980 [chapter 5].
13. Peltola H., Makela H., Kayhty H., Jousimies H., Herva E., Hallstrom K., et al. Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children 3 months to 5 years of age. N Eng J Med 297 (1977) 686-691
14. Reingold A.L., Broome C.V., Hightower A.W., Ajello G.W., Bolan G.A., Adamsbaum C., et al. Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide vaccine. Lancet 2 (1985) 114-118
15. Greenwood B.M., Smith A.W., Hassan-King M., Bijlmer H.A., Shenton F.C., Hughes A.S., et al. The efficacy of meningococcal polysaccharide vaccines in preventing group A meningococcal disease in The Gambia, West Africa. Trans R Soc Trop Med Hyg 80 (1986) 1006-1007
16. World Health Organization. Surveillance integrée des maladies prioritaires et riposte dans le bloc de l'Afrique de l'Ouest. Bulletin d'information et de retro-information N 12. WHO. ICST/CSR/WAB, 2006.